Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

Objective: To compare the treatment costs of insulin glargine (IG; Lantus®) to detemir (ID; Levemir®), both combined with bolus insulin aspart (NovoRapid®) in type 2 diabetes (T2D) in Germany. Methods: Cost comparison was based on data of a 1-year randomised controlled trial [1]. IG was administered...

Full description

Bibliographic Details
Main Authors: Dippel, Franz-Werner, Dietrich, Eva Susanne, Pscherer, Stefan, Neilson, Aileen Rae
Format: Article
Language:deu
Published: German Medical Science GMS Publishing House 2010-01-01
Series:GMS German Medical Science
Subjects:
insulin glargine
insulin detemir
basal insulin
type 2 diabetes
cost analysis
Online Access:http://www.egms.de/en/journals/gms/2010-8/000106.shtml

Internet

http://www.egms.de/en/journals/gms/2010-8/000106.shtml

Similar Items